Repros Therapeutics Inc (RPRX) financial statements (2020 and earlier)

Company profile

Business Address 2408 TIMBERLOCH PL
WOODLANDS, TX 77380
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments921477624
Cash and cash equivalents921477624
Inventory, net of allowances, customer advances and progress billings   22
Inventory   22
Prepaid expense and other current assets0
Other undisclosed current assets000(1)(2)
Total current assets:921477625
Noncurrent Assets
Property, plant and equipment00000
Intangible assets, net (including goodwill)   32
Intangible assets, net (excluding goodwill)   32
Total noncurrent assets:00032
TOTAL ASSETS:921477927
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:33344
Accounts payable22233
Accrued liabilities11111
Other undisclosed accounts payable and accrued liabilities0(0)(0)00
Other undisclosed current liabilities(0)00(0)(0)
Total current liabilities:33344
Noncurrent Liabilities
Total liabilities:33344
Stockholders' equity
Stockholders' equity attributable to parent, including:619447523
Common stock00000
Treasury stock, value(1)(1)(1)(1)(1)
Additional paid in capital327322318314234
Accumulated deficit(320)(302)(273)  
Other undisclosed stockholders' equity attributable to parent   (238)(210)
Total stockholders' equity:619447523
TOTAL LIABILITIES AND EQUITY:921477927

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Gross profit:00000
Operating expenses(17)(29)(33)(28)(18)
Other operating income, net
(Noninterest Income, Other Operating Income)
    0
Operating loss:(17)(29)(33)(28)(18)
Nonoperating income
(Investment Income, Nonoperating)
  000
Net loss:(17)(29)(33)(28)(18)
Other undisclosed net income (loss) attributable to parent  00(0)
Net loss available to common stockholders, diluted:(17)(29)(33)(28)(18)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(17)(29)(33)(28)(18)
Comprehensive loss, net of tax, attributable to parent:(17)(29)(33)(28)(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: